- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/115 - Paramyxoviridae, e.g. parainfluenza virus
Patent holdings for IPC class C07K 14/115
Total number of patents in this class: 154
10-year publication summary
5
|
6
|
5
|
2
|
9
|
4
|
4
|
12
|
12
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Centre National de La Recherche Scientifique | 10595 |
6 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 374 |
6 |
University of Georgia Research Foundation, Inc. | 1044 |
6 |
Boehringer Ingelheim Vetmedica GmbH | 1277 |
5 |
Institute for Research in Biomedicine | 101 |
5 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2886 |
5 |
Board of Regents, The University of Texas System | 5891 |
4 |
Janssen Vaccines & Prevention B.V. | 311 |
4 |
Zoetis Services LLC | 1533 |
4 |
Icahn School of Medicine at Mount Sinai | 962 |
3 |
Les Hospices Civils de Lyon | 3 |
3 |
Universite Claude Bernard Lyon 1 | 1034 |
3 |
Icosavax, Inc. | 37 |
3 |
Pfizer Inc. | 3396 |
2 |
Glaxosmithkline Biologicals S.A. | 1651 |
2 |
Biocomo Inc. | 9 |
2 |
Crucell Holland B.V. | 89 |
2 |
Dynavax Technologies Corporation | 117 |
2 |
ID Biomedical Corporation of Quebec | 19 |
2 |
ID Pharma Co., Ltd. | 43 |
2 |
Other owners | 83 |